Diagnosis (Laboratory other parameters)

Version vom 22. Juni 2020, 13:28 Uhr

Glucose
32360710 2020. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes

Presepsin
32333860 2020. Presepsin in risk stratification of SARS-CoV-2 patients

Procalcitonin
32344321 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19

SAA serum amyloid a
32277967 ä. SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19)

suPAR
32354367 2020. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

CRP
32368728 ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study
32344321 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
32281668 2020. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early
32455147 ä. C reactive protein level may predict the risk of COVID-19 aggravation

IL-6
32344321 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
32259560 ä. Interleukin-6 as a potential biomarker of COVID-19 progression
32414693 2020. Interleukin-6 levels in children developing SARS-CoV-2 infection
32297995 2020. High IL-6/IFN-gamma ratio could be associated with severe disease in COVID-19 patients

NLratio
32283162 ä. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19
32242828 2020. Decreased "WBC*LYM" was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan

Troponin
32348472 ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?

Eosinophils

32315421 ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)

IL2R on lymphcytes'
32365221 2020. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19

tumor markers
32347972 2020. Elevations of serum cancer biomarkers correlate with severity of COVID-19

profiling multiple parameters, reviews
32283164 ä. Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China
32324595 2020. The laboratory tests and host immunity of COVID-19 patients with different severity of illness
32301746 2020. Routine blood tests as a potential diagnostic tool for COVID-19
32119647 2020. Laboratory abnormalities in patients with COVID-2019 infection
32172227 2020. Laboratory abnormalities in children with novel coronavirus disease 2019

32181911 ä. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID?19
C7107806 ä. Elevated levels of plasma cytokines in COVID-19 reflect viral load and lung injury
32452410 2020. Association of viral load with serum biomakers among COVID-19 cases